Pristimerin Promotes Ubiquitination of HSPA8 and Activates the VAV1/ERK Pathway to Suppress TNBC Proliferation

Pristimerin Promotes Ubiquitination of HSPA8 and Activates the VAV1/ERK Pathway to Suppress TNBC Proliferation

Abstract Triple‐negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis. The natural compound pristimerin has shown promising anti‐tumor effect. Here, it is found that pristimerin significantly triggered the activation of autophagy initiation and induced apoptosis in TNBC....

Full description

Bibliographic Details
Main Authors: Qin‐Wen Liu, Qi‐Ling Fan, Jia‐Ying Chen, Jing‐Xin Liu, Yi Li, Qian Luo, Yu‐Peng Chen, Hang‐Tian Wu, An‐Qi Xu, Sheng Wang, Ai‐Ping Lu, Dao‐Gang Guan
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Advanced Science
Subjects:
HSPA8
pristimerin
triple‐negative breast cancer
VAV1/ERK pathway
Online Access:https://doi.org/10.1002/advs.202413174

Internet

https://doi.org/10.1002/advs.202413174

Similar Items